All of our results feed back into our drug discovery and drug development platform – the Recursion Operating System – in a continuously improving feedback loop.

Sep 1, 2017 · Stay updated with the latest press releases and news from Recursion. Dive into our achievements, announcements, and more. Explore now!

Nov 5, 2013 · We are not here to make a few medicines. We are here to reimagine how medicines are made. The Recursion mindset is the deep belief and commitment to …

Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …

Mar 12, 2025 · Recursion has partnered with two companies – Helix and Tempus — to gain access to extensive multimodal, de-identified patient data – approximately 20 petabytes for …

Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!

May 28, 2025 · That’s why we’ve not only been building massive fit-for-purpose datasets at Recursion, but releasing smaller open source versions of these datasets to accelerate the …

Get In Touch 41 S Rio Grande Street Salt Lake City, UT 84101 phone: (385) 269-0203 [email protected] Get Involved Careers Investor Relations

The release of Boltz-2 – a new machine learning model from MIT and Recursion that cannot only predict the 3D structure of ligand/protein complexes but predict their binding affinity with new …

Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …